Lista de obras -

2210. An Online Survey of Hepatitis C Testing Attitudes and Practice Habits Among Residents at an Urban Medical Center

A forgotten population: older adults with newly diagnosed HIV.

artículo científico publicado en 2014

Advances in antiretroviral therapy. Highlights of the 11th Conference on Retroviruses and Opportunistic Infections, February 8-11, 2004, San Francisco, California, USA.

artículo científico publicado en 2004

Anaemia in acute HIV-1 subtype C infection

artículo científico publicado en 2008

Antibody Fc effector functions and IgG3 associate with decreased HIV-1 risk

scientific article published on 01 November 2019

Antibody Resistance of SARS-CoV-2 Variants B.1.351 and B.1.1.7

artículo científico publicado en 2021

Antibody Resistance of SARS-CoV-2 Variants B.1.351 and B.1.1.7

Antigenic competition in CD4+ T cell responses in a randomized, multicenter, double-blind clinical HIV vaccine trial

artículo científico publicado en 2019

Cabotegravir in the treatment and prevention of Human Immunodeficiency Virus-1.

artículo científico publicado en 2018

Challenges of diagnosing acute HIV-1 subtype C infection in African women: performance of a clinical algorithm and the need for point-of-care nucleic-acid based testing ⬇️

artículo científico publicado en 2013

Combination therapy with polymyxin B for the treatment of multidrug-resistant Gram-negative respiratory tract infections

artículo científico publicado en 2004

Combining Google Earth and GIS mapping technologies in a dengue surveillance system for developing countries

artículo científico publicado en 2009

DNA Priming Increases Frequency of T-Cell Responses to a Vesicular Stomatitis Virus HIV Vaccine with Specific Enhancement of CD8+ T-Cell Responses by Interleukin-12 Plasmid DNA.

artículo científico publicado en 2017

Effect of rAd5-Vector HIV-1 Preventive Vaccines on HIV-1 Acquisition: A Participant-Level Meta-Analysis of Randomized Trials

artículo científico publicado en 2015

Efficacy trial of a DNA/rAd5 HIV-1 preventive vaccine

artículo científico publicado en 2013

Engaging members of African American and Latino communities in preventive HIV vaccine trials

artículo científico publicado en 2009

HIV prevention in high-risk women in South Africa: condom use and the need for change

artículo científico publicado en 2012

HIV serostatus disclosure is not associated with safer sexual behavior among HIV-positive men who have sex with men (MSM) and their partners at risk for infection in Bangkok, Thailand ⬇️

artículo científico publicado el 23 de diciembre de 2012

HIV-1 VACCINES. Diversion of HIV-1 vaccine-induced immunity by gp41-microbiota cross-reactive antibodies

artículo científico publicado en 2015

Higher T-Cell Responses Induced by DNA/rAd5 HIV-1 Preventive Vaccine Are Associated With Lower HIV-1 Infection Risk in an Efficacy Trial

artículo científico publicado en 2017

Host genetic polymorphisms associated with innate immune factors and HIV-1 ⬇️

artículo científico publicado el 1 de septiembre de 2011

In Pursuit of an HIV Vaccine: Designing Efficacy Trials in the Context of Partially Effective Nonvaccine Prevention Modalities ⬇️

artículo científico publicado el 25 de junio de 2013

Intentions to Use Preexposure Prophylaxis Among Current Phase 2B Preventive HIV-1 Vaccine Efficacy Trial Participants ⬇️

artículo científico publicado el 1 de julio de 2013

Lessons for Patient Education Around Long-Acting Injectable PrEP: Findings from a Mixed-Method Study of Phase II Trial Participants

artículo científico publicado en 2017

Malnutrition in HIV-Infected Children Is an Indicator of Severe Disease with an Impaired Response to Antiretroviral Therapy

artículo científico publicado en 2017

Metabolic Syndrome After HIV Acquisition in South African Women.

artículo científico publicado en 2016

Missed Opportunities for Engagement in the Prevention Continuum in a Predominantly Black and Latino Community in New York City

artículo científico publicado en 2018

Positive or Not, that is the Question: HIV Testing for Individuals on Pre-Exposure Prophylaxis (PrEP).

artículo científico publicado en 2018

Prevalence and predictors of metabolic syndrome among HIV-infected and HIV-uninfected women in the Women's Interagency HIV Study

artículo científico publicado en 2008

Provider attitudes toward oral preexposure prophylaxis for HIV prevention among high-risk men who have sex with men in Lima, Peru

artículo científico publicado en 2014

Recommendations for the follow-up of study participants with breakthrough HIV infections during HIV/AIDS biomedical prevention studies ⬇️

artículo científico publicado el 24 de abril de 2013

Recruitment by a geospatial networking application for research and practice: the New York City experience

artículo científico publicado en 2014

Representation of Latinos and Blacks in screening for and enrollment into preventive HIV vaccine trials in New York City

artículo científico publicado en 2015

Safety and Immunogenicity of a Recombinant Adenovirus Serotype 35-Vectored HIV-1 Vaccine in Adenovirus Serotype 5 Seronegative and Seropositive Individuals

artículo científico publicado en 2015

Safety and tolerability of HIV-1 multiantigen pDNA vaccine given with IL-12 plasmid DNA via electroporation, boosted with a recombinant vesicular stomatitis virus HIV Gag vaccine in healthy volunteers in a randomized, controlled clinical trial

artículo científico publicado en 2018

Safety and tolerability of long-acting cabotegravir injections in HIV-uninfected men (ECLAIR): a multicentre, double-blind, randomised, placebo-controlled, phase 2a trial

artículo científico

Safety, pharmacokinetics, and immunological activities of multiple intravenous or subcutaneous doses of an anti-HIV monoclonal antibody, VRC01, administered to HIV-uninfected adults: Results of a phase 1 randomized trial.

artículo científico publicado en 2017

Sieve analysis of breakthrough HIV-1 sequences in HVTN 505 identifies vaccine pressure targeting the CD4 binding site of Env-gp120.

artículo científico publicado en 2017

Testing the waters: Ethical considerations for including PrEP in a phase IIb HIV vaccine efficacy trial

artículo científico publicado en 2015

The challenge of HIV-1 subtype diversity

artículo científico publicado en 2008

Timing of plasmid cytokine (IL-2/Ig) administration affects HIV-1 vaccine immunogenicity in HIV-seronegative subjects

artículo científico publicado en 2011

Translational Research Insights From Completed HIV Vaccine Efficacy Trials ⬇️

artículo científico publicado el 1 de julio de 2013

Using conjoint analysis to determine the impact of product and user characteristics on acceptability of rectal microbicides for HIV prevention among Peruvian men who have sex with men.

artículo científico publicado en 2015

Lista de obras de

2210. An Online Survey of Hepatitis C Testing Attitudes and Practice Habits Among Residents at an Urban Medical Center

A forgotten population: older adults with newly diagnosed HIV.

Advances in antiretroviral therapy. Highlights of the 11th Conference on Retroviruses and Opportunistic Infections, February 8-11, 2004, San Francisco, California, USA.

Anaemia in acute HIV-1 subtype C infection

Antibody Fc effector functions and IgG3 associate with decreased HIV-1 risk

Antibody Resistance of SARS-CoV-2 Variants B.1.351 and B.1.1.7

Antibody Resistance of SARS-CoV-2 Variants B.1.351 and B.1.1.7

Antigenic competition in CD4+ T cell responses in a randomized, multicenter, double-blind clinical HIV vaccine trial

Cabotegravir in the treatment and prevention of Human Immunodeficiency Virus-1.

Challenges of diagnosing acute HIV-1 subtype C infection in African women: performance of a clinical algorithm and the need for point-of-care nucleic-acid based testing ⬇️

Combination therapy with polymyxin B for the treatment of multidrug-resistant Gram-negative respiratory tract infections

Combining Google Earth and GIS mapping technologies in a dengue surveillance system for developing countries

DNA Priming Increases Frequency of T-Cell Responses to a Vesicular Stomatitis Virus HIV Vaccine with Specific Enhancement of CD8+ T-Cell Responses by Interleukin-12 Plasmid DNA.

Effect of rAd5-Vector HIV-1 Preventive Vaccines on HIV-1 Acquisition: A Participant-Level Meta-Analysis of Randomized Trials

Efficacy trial of a DNA/rAd5 HIV-1 preventive vaccine

Engaging members of African American and Latino communities in preventive HIV vaccine trials

HIV prevention in high-risk women in South Africa: condom use and the need for change

HIV serostatus disclosure is not associated with safer sexual behavior among HIV-positive men who have sex with men (MSM) and their partners at risk for infection in Bangkok, Thailand ⬇️

HIV-1 VACCINES. Diversion of HIV-1 vaccine-induced immunity by gp41-microbiota cross-reactive antibodies

Higher T-Cell Responses Induced by DNA/rAd5 HIV-1 Preventive Vaccine Are Associated With Lower HIV-1 Infection Risk in an Efficacy Trial

Host genetic polymorphisms associated with innate immune factors and HIV-1 ⬇️

In Pursuit of an HIV Vaccine: Designing Efficacy Trials in the Context of Partially Effective Nonvaccine Prevention Modalities ⬇️

Intentions to Use Preexposure Prophylaxis Among Current Phase 2B Preventive HIV-1 Vaccine Efficacy Trial Participants ⬇️

Lessons for Patient Education Around Long-Acting Injectable PrEP: Findings from a Mixed-Method Study of Phase II Trial Participants

Malnutrition in HIV-Infected Children Is an Indicator of Severe Disease with an Impaired Response to Antiretroviral Therapy

Metabolic Syndrome After HIV Acquisition in South African Women.

Missed Opportunities for Engagement in the Prevention Continuum in a Predominantly Black and Latino Community in New York City

Positive or Not, that is the Question: HIV Testing for Individuals on Pre-Exposure Prophylaxis (PrEP).

Prevalence and predictors of metabolic syndrome among HIV-infected and HIV-uninfected women in the Women's Interagency HIV Study

Provider attitudes toward oral preexposure prophylaxis for HIV prevention among high-risk men who have sex with men in Lima, Peru

Recommendations for the follow-up of study participants with breakthrough HIV infections during HIV/AIDS biomedical prevention studies ⬇️

Recruitment by a geospatial networking application for research and practice: the New York City experience

Representation of Latinos and Blacks in screening for and enrollment into preventive HIV vaccine trials in New York City

Safety and Immunogenicity of a Recombinant Adenovirus Serotype 35-Vectored HIV-1 Vaccine in Adenovirus Serotype 5 Seronegative and Seropositive Individuals

Safety and tolerability of HIV-1 multiantigen pDNA vaccine given with IL-12 plasmid DNA via electroporation, boosted with a recombinant vesicular stomatitis virus HIV Gag vaccine in healthy volunteers in a randomized, controlled clinical trial

Safety and tolerability of long-acting cabotegravir injections in HIV-uninfected men (ECLAIR): a multicentre, double-blind, randomised, placebo-controlled, phase 2a trial

Safety, pharmacokinetics, and immunological activities of multiple intravenous or subcutaneous doses of an anti-HIV monoclonal antibody, VRC01, administered to HIV-uninfected adults: Results of a phase 1 randomized trial.

Sieve analysis of breakthrough HIV-1 sequences in HVTN 505 identifies vaccine pressure targeting the CD4 binding site of Env-gp120.

Testing the waters: Ethical considerations for including PrEP in a phase IIb HIV vaccine efficacy trial

The challenge of HIV-1 subtype diversity

Timing of plasmid cytokine (IL-2/Ig) administration affects HIV-1 vaccine immunogenicity in HIV-seronegative subjects

Translational Research Insights From Completed HIV Vaccine Efficacy Trials ⬇️

Using conjoint analysis to determine the impact of product and user characteristics on acceptability of rectal microbicides for HIV prevention among Peruvian men who have sex with men.